For the Inventor, By the Inventor

Enter assignee name

Parsippany, NJ, United States of America

Zoetis Services LLC

Calculating rank

USPTO Granted Patents = 225

% Expired Patents = 7.6

CIPO Patents = 31

EPO Patents = 122

Trademarks = 280

Forward Citations = 480

Loading Chart...

Loading Chart...

319 inventors (with patents filed for the assignee):

Paul Joseph Dominowski (23 out of 29 patents)

Richard Andrew Ewin (20 out of 26 patents)

Steven Alan Dunham (18 out of 19 patents)

4. William Dongwook Suh (15 out of 16 patents)

5. John Morgan Hardham (15 out of 26 patents)

6. Rajesh K Mehra (14 out of 46 patents)

7. Jay Gregory Calvert (13 out of 33 patents)

8. Kenneth P Aron (13 out of 52 patents)

9. Gregory Paul Nitzel (13 out of 26 patents)

10. Jeffrey E Galvin (12 out of 12 patents)

11. James R Kulawik, Ii (12 out of 12 patents)

12. John Keith Garrett (12 out of 12 patents)

13. Tracy L Ricker (12 out of 12 patents)

14. Megan Marie Smutzer (12 out of 12 patents)

15. Sebastian C J Steiniger (10 out of 10 patents)

Core Competencies:

Anti-NGF Antibodies

Adjuvant Compositions

Vaccine Administration

Immunomodulating Azalides

Porcine Epidemic Diarrhea

Microfluidic Devices

Serotonin Inhibitors

Live-Attenuated Vaccines

Nucleic Acids

Antimicrobial Peptides

Equine Influenza

Canine Antibodies

225 patents: Sort by Forward Citations

1. 12760107 - FELINE ANTIBODY VARIANTS (2026-10-13),

2. 12729235 - CANINIZED ANTI-TGFBETA ANTIBODIES (2026-09-08),

3. 12704510 - Signal amplification in plasmonic specific-binding partner assays (2026-08-11),

4. 12668582 - Phosphodiesterase 3 (PDE3) inhibitors (2026-06-30),

5. 12582768 - Medicament delivery system, and associated method (2026-03-24),

6. 12582662 - Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative (2026-03-24),

7. 12552871 - Nucleic Acids Encoding Humanized Anti-NGF Antibodies (2026-02-17),

8. 12521433 - Novel Adjuvant Compositions (2026-01-13),

9. 12497459 - Nucleic Acids Encoding Canine Anti-NGF Antibodies and Methods Thereof (2025-12-16),

10. 12458001 - Singulating device for organisms (2025-11-04),

11. 12440556 - Genetically modified cell line for production of Marek's disease virus vaccine and methods of making and using the same (2025-10-14),

12. 12419941 - Poultry drinking water-based vaccine delivery system and method (2025-09-23),

13. 12390441 - Immunomodulating o-het/aryl azalides (2025-08-19),

14. 12390440 - Immunomodulating trifluoromethyl-aminal azalides (2025-08-19),

15. 12378233 - Immunomodulating azalides (2025-08-05),

Company Overview

Zoetis Services LLC, headquartered in Parsippany, NJ, specializes in the development and manufacturing of veterinary vaccines. The company focuses on innovative technologies in the field of animal health, particularly in areas such as anti-NGF antibodies, adjuvant compositions, and live-attenuated vaccines. Zoetis is dedicated to enhancing animal health through advanced immunomodulating agents and microfluidic devices, addressing critical challenges in veterinary medicine, including diseases like Porcine Epidemic Diarrhea.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

225 Patents

#4 in Parsippany, NJ

#89 in New Jersey

#1,862 in US

#3,805 in the World

Parsippany, NJ, United States of America

Zoetis Services LLC

Forward Citations = 480

319 inventors:

Paul Joseph Dominowski (23 out of 29 patents)

Richard Andrew Ewin (20 out of 26 patents)

Steven Alan Dunham (18 out of 19 patents)

4. William Dongwook Suh (15 out of 16 patents)

5. John Morgan Hardham (15 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Zoetis Services LLC. Retrieved from https://idiyas.com/company/zoetis-services

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…